Efficacy of anti-PD-1 antibody combined with neoadjuvant concurrent chemoradiotherapy in the treatment of resectable locally advanced thoracic esophageal squamous cell carcinoma

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2019
This article has no abstract
Epistemonikos ID: 05ef20364e52985b803e573fd97b5a0cf54d7467
First added on: Apr 07, 2025